Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.
UPC stock price ended at $2.67 on 水曜日, after rising 2.69%
On the latest trading day May 13, 2026, the stock price of UPC rose by 2.69%, climbing from $2.60 to $2.67. During the session, the stock saw a volatility of 4.62%, with prices oscillating between a daily low of $2.60 and a high of $2.72. Notably, trading volume dropped by 8.3K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 15.1K shares were traded, equating to a market value of approximately $1.4M.